Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stephen Anthony, DO
Sumitomo Pharma America, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Community Medical Providers
Clovis, California, United States
- City of Hope National Medical Center, City of Hope Medical Center
Duarte, California, United States
- Ronald Reagan Ucla Medical Center
Los Angeles, California, United States
- University of California, San Francisco Medical Center
San Francisco, California, United States
- Advent Health Medical Group Blood & Marrow Transplant at Orlando
Orlando, Florida, United States
- Orlando Health, Inc, Univ of Florida Health Cancer Center
Orlando, Florida, United States
- Indiana Blood and Marrow Translplantation - Clinic
Indianapolis, Indiana, United States
- University of Kansas Medical Center
Westwood, Kansas, United States
- Ochsner Medical Center
New Orleans, Louisiana, United States
- University of New Mexico
Albuquerque, New Mexico, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Columbia University Medical Center
New York, New York, United States
- University of North Carolina (unc)
Chapel Hill, North Carolina, United States
- Ohio State University
Columbus, Ohio, United States
- Oregon Health & Sciences University - Knight Cancer Institute - Center for Hematologic Malignancies
Portland, Oregon, United States
- Allegheny Health Network
Pittsburgh, Pennsylvania, United States
- Baylor University Center
Dallas, Texas, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Jan 2020
- Primary completion
- 22 Apr 2021
- Completion
- 14 May 2021
- Last update posted
- 9 Nov 2023
- Registered enrollment
- 11
- Registry id
- NCT03969420
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.